An Evidence-Based Supplement Formulated to Improve Testosterone Levels* ROCKVILLE, MD / ACCESS Newswire / April 30, 2026 / Theralogix, a trusted leader in nutritional supplements, is proud to announce ...

SOLANA BEACH, CA / ACCESS Newswire / April 29, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the ...

"Without clinical evidence, without public notice, and without congressional authorization, the federal government inserted psychoactive consumer products into Medicare - then filed a brief defending ...

IntroductionThe global healthcare IT market is witnessing a significant transformation, driven by rapid technological advancements and a growing emphasis on digital healthcare ecosystems, and is ...

Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio Chiesi agreed to acquire KalVista Pharmaceuticals for $27.00 per share in cash, representing an equity ...

First-in-Class enVVe system to be evaluated in TAVVE U.S. Pivotal TrialClinical site activation and patient enrollment expected to commence later this yearLarge unmet clinical need for approximately 3 ...

As digital doomscrolling becomes a defining habit of modern life, new research reveals how the constant influx of distressing ...

LUND, SE / ACCESS Newswire / April 29, 2026 / The Annual General Meeting (AGM) of BioInvent International AB (BioInvent) ...

Meet with Modular Medical CEO Jeb BesserThere are 4.8 million individuals with diabetes in the US that require daily insulin.

MESA, AZ / ACCESS Newswire / April 29, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) ("the Company") today announced a major upgrade to its AI-powered mobile recipe application, Snapshot Recipes, ...

Delivering advanced OCT, fundus imaging, and optical biometry systems to support accurate diagnostics and efficient workflows for eye care professionals worldwide SINGAPORE, SG / ACCESS Newswire / ...

GOTHENBURG, SE / ACCESS Newswire / April 29, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, announced today that ...